Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels (Q40326009)
Jump to navigation
Jump to search
scientific article published on January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels |
scientific article published on January 2006 |
Statements
1 reference
Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels (English)
1 reference
Robert Wild
1 reference
Krista Fager
1 reference
Christine Flefleh
1 reference
David Kan
1 reference
Ivan Inigo
1 reference
Stephen Castaneda
1 reference
Feng Roger Luo
1 reference
Amy Camuso
1 reference
Kelly McGlinchey
1 reference
William C Rose
1 reference
1 January 2006
1 reference
1 reference
Identifiers
1 reference